CytomX Therapeutics (CTMX) Prepaid Assets (2014 - 2026)

CytomX Therapeutics has reported Prepaid Assets for 13 years, with the latest figure at $5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 20.0% year-over-year to $5.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.7 million (up 20.0% YoY), and the FY2025 full-year result was $4.9 million, up 35.68% from the prior year.
• Prepaid Assets for Q1 2026 stood at $5.7 million, up from $4.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $7.5 million in Q4 2022, with the low at $3.1 million in Q2 2024.
• Historically, Prepaid Assets has averaged $4.7 million across 5 years, with a median of $4.7 million in 2023.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 74.24% — and 2024, when it plunged 43.37%.
• CytomX Therapeutics' Prepaid Assets stood at $7.5 million in 2022, then tumbled by 33.1% to $5.0 million in 2023, then dropped by 28.35% to $3.6 million in 2024, then jumped by 35.68% to $4.9 million in 2025, then advanced by 18.27% to $5.7 million in 2026.
• The last three Prepaid Assets figures came in at $5.7 million (Q1 2026), $4.9 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.